MToole
Active member
- Joined
- Apr 16, 2016
- Messages
- 87
- Reason
- PALS
- Diagnosis
- 02/2012
- Country
- US
- State
- IL
- City
- Elmhurst
See the following links for the presentations from the 10th Annual Les Turner Symposium on ALS (November 2020)
[link to main page removed due to donation link]
Keynote Address: Sabrina Paganoni, MD, PhD – “The HEALEY ALS Platform Trial: an innovative and collaborative trial to accelerate the development of effective treatments for ALS”
Clinical Conversations Panel – featuring Colin Franz, MD, PhD, Senda Ajroud-Driss, MD, Sabrina Paganoni, MD, PhD and Lisa F. Wolfe, MD
“Neurons undergo pathogenic metabolic reprograming in modes of familial ALS” – Robert Kalb, MD
“On mechanisms and markers of ALS” – Tania Gendron, PhD
“Aggregation-dependent and independent mechanisms of toxicity in TDP-43 and FUS proteinopathies” – Magdalini Polymenidou, PhD
“Novel Insights into the Molecular Mechanisms Driving Neuronal Degeneration in Genetic ALS” – Evangelos Kiskinis, PhD
“Cellular and Molecular Basis of Upper Motor Neuron Degeneration in ALS” – Hande Ozdinler, PhD
“TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6” – Daniela C. Zarnescu, PhD
“ALS5 and mouse models: Molecular insight into neurodegenerative diseases” – Han-Xiang Deng, MD, PhD
“Using C. elegans genetics to inform human neurodegenerative disease mechanisms” – Brian Kraemer, PhD
[link to main page removed due to donation link]
Keynote Address: Sabrina Paganoni, MD, PhD – “The HEALEY ALS Platform Trial: an innovative and collaborative trial to accelerate the development of effective treatments for ALS”
Clinical Conversations Panel – featuring Colin Franz, MD, PhD, Senda Ajroud-Driss, MD, Sabrina Paganoni, MD, PhD and Lisa F. Wolfe, MD
“Neurons undergo pathogenic metabolic reprograming in modes of familial ALS” – Robert Kalb, MD
“On mechanisms and markers of ALS” – Tania Gendron, PhD
“Aggregation-dependent and independent mechanisms of toxicity in TDP-43 and FUS proteinopathies” – Magdalini Polymenidou, PhD
“Novel Insights into the Molecular Mechanisms Driving Neuronal Degeneration in Genetic ALS” – Evangelos Kiskinis, PhD
“Cellular and Molecular Basis of Upper Motor Neuron Degeneration in ALS” – Hande Ozdinler, PhD
“TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6” – Daniela C. Zarnescu, PhD
“ALS5 and mouse models: Molecular insight into neurodegenerative diseases” – Han-Xiang Deng, MD, PhD
“Using C. elegans genetics to inform human neurodegenerative disease mechanisms” – Brian Kraemer, PhD
Last edited by a moderator: